LEBEL FRANCOIS (Chief Medical Officer) sold 16.5% of their position (50.23K shares) of SPECTRUM PHARMACEUTICALS INC on the open market
Open‑market sale worth $35.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/16/2022ACC: 0001209191-22-019341
Officer· Chief Medical Officer
Since Jun 2019
-50.23K
Net shares
Net seller
$35.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
50.23K disposed
Non-Derivative Transactions2
Common Stock, $0.001 par value
Direct
Shares
−25.13K
Price / share
$0.70
Trade value
$17.72K
% of position
8.2%
3/15/2022
305.32K→280.19K
Common Stock, $0.001 par value
Direct
Shares
−25.11K
Price / share
$0.71
Trade value
$17.72K
% of position
9.0%
3/16/2022
280.19K→255.09K
Total
Net shares
−50.23K
Net value
-$35.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 3/15/2022 | S · Sale | −25.13K | $0.70 | $17.72K | 8.2% | 305.32K | 280.19K |
| Common Stock, $0.001 par value Direct | 3/16/2022 | S · Sale | −25.11K | $0.71 | $17.72K | 9.0% | 280.19K | 255.09K |
| Total | −50.23K | -$35.44K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.001 par value
IndirectShares owned7.23K
Total
7.23K indirect7.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 7.23K | Indirect |
| Total | 7.23K | 7.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported